Literature DB >> 19657188

Semaphorin3F down-regulates the expression of integrin alpha(v)beta3 and sensitizes multicellular tumor spheroids to chemotherapy via the neuropilin-2 receptor in vitro.

Chenhong Zheng1, Qi Zhou, Feng Wu, Qiuping Peng, Airong Tang, Houjie Liang, Yanjun Zeng.   

Abstract

BACKGROUND: Multicellular resistance (MCR), i.e. decreased sensitivity to anticancer drugs compared with common monolayer cell (MC) cultures, depends partly on tumor cell-cell adhesion. Previous studies have shown that anti-adhesive therapies, including integrin alpha(v), beta(1) and alpha(v)beta(3) targeting, induced apoptosis and reversed the sensitivity of MCR.
METHODS: A model of three-dimensional cell culture was used to establish HT29 multicellular spheroid cells (MCS) and explore the effect of semaphorin3F (Sema3F) on integrin-mediated cell-cell interactions in MCS of a human colorectal adenocarcinoma cell line (HT29) and sensitization of HT29 MCS to 5-fluorouracil and oxaliplatin via a decrease in integrin alpha(v)beta(3).
RESULTS: Elevated expression of Sema3F led to the up-regulation neuropilin-2 (Nrp2) receptor expression and the down-regulation of integrin alpha(v)beta(3) expression. Furthermore, short interfering RNA of Nrp2 could reverse MCR.
CONCLUSION: Our study demonstrates that Sema3F can sensitize MCR by decreasing integrin alpha(v)beta(3)expression via the Nrp2 receptor. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19657188     DOI: 10.1159/000232449

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  6 in total

1.  Decreased expression of SEMA3A is associated with poor prognosis in gastric carcinoma.

Authors:  Chong Tang; Xuesong Gao; Hongbin Liu; Tian Jiang; Xiaofeng Zhai
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

Review 2.  Neuropilins Controlling Cancer Therapy Responsiveness.

Authors:  Virginia Napolitano; Luca Tamagnone
Journal:  Int J Mol Sci       Date:  2019-04-25       Impact factor: 5.923

3.  Semaphorin 3F induces colorectal cancer cell chemosensitivity by promoting P27 nuclear export.

Authors:  Miaomiao Tao; Hongbo Ma; Xiaoyuan Fu; Cancan Wang; Yanyan Li; Xiaoqiao Hu; Renming Lv; Gendou Zhou; Jun Wang; Ruyan Liu; Meiyu Zhou; Guofa Xu; Zexin Wang; Xiurong Qin; Yi Long; Qunzhen Huang; Min Chen; Qi Zhou
Journal:  Front Oncol       Date:  2022-09-02       Impact factor: 5.738

4.  Expression of semaphorin 3A and neuropilin 1 with clinicopathological features and survival in human tongue cancer.

Authors:  Xiao Song; Wei Zhang; Yang Zhang; Hong Zhang; Zhen Fu; Jin Ye; Lai Liu; Xiao Song; Yu Wu
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-11-01

5.  Overexpression of Semaphorin 3A is a Marker Associated with Poor Prognosis in Patients with Nasopharyngeal Carcinoma.

Authors:  Tomoko Imoto; Satoru Kondo; Naohiro Wakisaka; Pham Tahnh Hai; Noriko Seishima; Makoto Kano; Takayoshi Ueno; Harue Mizokami; Yosuke Nakanishi; Miyako Hatano; Kazuhira Endo; Hisashi Sugimoto; Makiko Moriyama-Kita; Tomokazu Yoshizaki
Journal:  Microorganisms       Date:  2020-03-17

Review 6.  The Role of Neuropilin-2 in the Epithelial to Mesenchymal Transition of Colorectal Cancer: A Systematic Review.

Authors:  Cristina Lungulescu; Valentina Ghimpau; Dan Ionut Gheonea; Daniel Sur; Cristian Virgil Lungulescu
Journal:  Biomedicines       Date:  2022-01-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.